Virological, Immunological, and Clinical Impact of Switching from Protease Inhibitors to Nevirapine or to Efavirenz in Patients with Human Immunodeficiency Virus Infection and Long-Lasting Viral Suppression

Author:

Negredo Eugenia1,Cruz Luís1,Paredes Roger2,Ruiz Lidia2,Fumaz Carmina R.1,Bonjoch Anna1,Gel Silvia1,Tuldrà Albert1,Balagué Montserrat2,Johnston Susan1,Arná Albert1,Jou Antoni1,Tural Cristina1,Sirera Guillem1,Romeu Joan1,Clotet Bonaventura12

Affiliation:

1. Lluita contra la SIDA Foundation, Badalona, Barcelona, Spain

2. “IrsiCaixa” Retrovirology Laboratory, Germans Trias i Pujol University Hospital, Badalona, Barcelona, Spain

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Reference26 articles.

1. For the Study 006 Team. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir and indinavir plus zidovudine and lamivudine in the treatment of HIV-infection in adults;Staszewski;N Engl J Med,1999

2. Efavirenz: shifting the HAART paradigm in adult HIV-1 infection;Moyle;Exp Opin Invest Drugs,1999

3. The ATLANTIC study: a randomized open-label trial comparing two protease inhibitors-sparing antiretroviral strategies versus a standard PI-containing regimen, 48-week data [abstract LB-22];Murphy,1999

4. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial;Montaner;JAMA,1998

5. Preliminary results of a randomized multicenter study comparing conbivir plus nelfinavir or nevirapine in HIV-infected naïve patients (COMBINE study) [abstract 510];Podzamczer,2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3